Intrepid Financial Planning Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$204K Sell
8,476
-90
-1% -$2.35K 0.07% 127
2026
Q1
$241K Hold
8,566
0.1% 109
2025
Q4
$213K Hold
8,566
0.08% 112
2025
Q3
$218K Sell
8,566
-428
-5% -$10.6K 0.08% 115
2025
Q2
$218K Sell
8,994
-8,258
-48% -$193K 0.09% 114
2025
Q1
$437K Sell
17,252
-500
-3% -$13.1K 0.2% 74
2024
Q4
$471K Sell
17,752
-593
-3% -$16.1K 0.2% 74
2024
Q3
$531K Sell
18,345
-830
-4% -$24.2K 0.23% 70
2024
Q2
$537K Sell
19,175
-203
-1% -$5.59K 0.23% 67
2024
Q1
$538K Sell
19,378
-1,170
-6% -$32.5K 0.23% 68
2023
Q4
$592K Sell
20,548
-5,000
-20% -$151K 0.28% 59
2023
Q3
$847K Buy
25,548
+5,156
+25% +$182K 0.44% 44
2023
Q2
$748K Sell
20,392
-800
-4% -$31.1K 0.36% 52
2023
Q1
$865K Hold
21,192
0.44% 46
2022
Q4
$1.09M Sell
21,192
-275
-1% -$13.2K 0.59% 40
2022
Q3
$939K Buy
21,467
+350
+2% +$17K 0.53% 41
2022
Q2
$1.11M Buy
+21,117
New +$1.08M 0.61% 38

Other funds holding PFE

Intrepid Financial Planning Group's PFE Position: Q2 2026 in Review

Intrepid Financial Planning Group reduced its Pfizer (PFE) stake by 1.1% in Q2 2026, selling an estimated $2.35K and leaving 8,476 shares worth $204K. The position accounts for 0.07% of the portfolio, ranked #127.

Intrepid Financial Planning Group first reported a position in PFE in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.11M in Q2 2022. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Intrepid Financial Planning Group held 8,476 shares of Pfizer worth $204K as of Q2 2026.
  • Intrepid Financial Planning Group sold 90 Pfizer shares in Q2 2026, an estimated $2.35K.
  • Pfizer made up 0.07% of Intrepid Financial Planning Group's portfolio in Q2 2026, its #127 holding.
  • Intrepid Financial Planning Group first reported a position in Pfizer in Q2 2022 and has held it in 17 quarters since.
  • Intrepid Financial Planning Group's Pfizer position peaked at $1.11M in Q2 2022.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Intrepid Financial Planning Group's 13F filing for Q2 2026, filed 12 Aug 2026.